Source: Gilead and Hepatitis.UW.Edu
You maybe eligible to save $50 with Medicare, Medicaid and most insurers approved.
Author: Tim Reeves a hepatitis C survivor and pharmacist
What is EPCLUSA® ?
EPCLUSA® is a prescription drug that treats chronic hepatitis C virus (HCV).
Its a combination drug with sofosbuvir (discovered only in 2012) and velpatasvir.
It is a tablet that is taken once a day, for 84 days or 12 weeks.
The good news about EPCLUSA® is it treats 1 to 6 genotypes of the hepatitis C virus.
Genotype is the genetic code of the virus.
The hepatitis C virus genotypes are 1, 2, 3, 4, 5 and 6.
Its called a pangenotype treatment for HCV.
Pan meaning that it covers all genotypes, except 7.
(Genotype 7 is found only in Democratic Republic of Congo)
Its a tablet a day to cure hepatitis C in just 12 weeks.
That is a real game changer for hepatitis C treatment.
Before, many of my friends and myself included, would have to be on pegylated interferon and ribavirin.
Those were horrible times.
I was always exhausted.
Those pegylated interferon shots were really hard on my system.
EPCLUSA® is much easier on the body.
Are there any side effects with EPCLUSA®?
Yes and no.
Most folks don’t have any side effects.
In clinical studies less than 5% have reported to have side effects.
For me, I was just tired going in to the second week of treatment.
A little bit of brain fog for about 4 days and then it was smooth sailing.
I am inspired to share my story with others.
I let go and got cured for hepatitis C, you can too.
EPCLUSA® cost is $78,078.
Authorized EPCLUSA® generic cost is only $850 for full 12 weeks treatment (apply for $50 off)
Its affordable and has a very high cure rate.
EPCLUSA® Treatment (sofosbuvir 400mg ledipasvir 90mg)
Treatment for – chronic hepatitis C virus (HCV)
EPCLUSA® Treatment Duration: One oral tablet a day for 84 days or 12 weeks.
Patent – Gilead Sciences
Manufacturer – Gilead Sciences
Distribution – Local pharmacies, online pharmacies, hospital pharmacies
Strength – 100mg velpatasvir and 400mg sofosbuvir
Treats Hepatitis C Virus Genotypes – 1, 2, 3, 4, 5 or 6
Success Rate: 94% to 99% after 12 weeks treatment for most genotypes.
Money Back Guarantee: 100%, no questions asked.
What is the most important thing about EPCLUSA®?
Do not take EPCLUSA® with amiodarone (Cordarone®, Nexterone®, Pacerone® medications.
These medications have been known to cause slow heart rate that may lead to death.
What other safety information I should know ?
Make sure you tell your doctor/healthcare provider if you have or had the following :
- hepatitis B virus can be reactivated
- liver transplant
- kidney disease
If you are pregnant or breastfeeding do not take EPCLUSA®.
Not enough information is known about EPCLUSA®, if it will pass to the fetus or pass through breast milk.
Do not get pregnant or be pregnant when you take ribavirin with EPCLUSA®.
Ribavirin is very dangerous and should not be taken by all pregnant women.
Ribavirin should be stopped for atleast 6 months by both men and women prior to planning for pregnancy.
EPCLUSA® generic name:
Gilead licensed EPCLUSA® generic name is velpatasvir and sofosbuvir.
The name represents the two important ingredients of EPCLUSA®.
The original EPCLUSA® and the generic are identical in ingredients and molecule.
Dosage & administration:
- once a day oral tablet taken orally for 84 days (12 weeks).
- for retreatment can be taken with ribavirin, consult with your doctor.
Most common side effects:
If you experience any severe allergic reaction to this medication, please call 911 or your physician immediately.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.